← Back
product
Abilify
Last discussed Aug 17, 2026
Aripiprazole, an atypical antipsychotic approved for augmentation of antidepressants in treatment-resistant depression, among other indications.
Recently discussed in
404 ‒ Mental health beyond neurotransmitters: hormones in psychiatry, psychedelic therapies, & more
Linus Abrams · Aug 17, 2026
What creators say
LA
Linus Abrams
mentioned
Used for: Augmentation strategy added on top of antidepressants for treatment-resistant depression
"Atypical antipsychotics are also indicated for treatment-resistant depression — drugs like Rexulti, Abilify, Brexpiprazole, Aripiprazole, Ziprasidone, Olanzapine. Those drugs are often quite effective as augmentation strategies adding on top of an..."
More from Linus Abrams →Keep exploring
About this data
- ✓44,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out
Get an email when a new creator recommends it